semaglutide risks The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added risks of taking semaglutide semaglutide

We identified downregulation of mitochondrial programs in multiple non-proximal tubular cell populations compared with their counterparts in healthy kidneys

One of the reasons for the disparity in findings is the lack of high-quality alpha cell models

Peptide dosage depends on the medical condition youre treating

The tirzepatide factor: the middle ground No comparison of Ozempic and retatrutide is complete without acknowledging the medication that sits between them

And that's where the endometriosis conversation starts to get interesting

Cardiovascular and Metabolic Benefits : Semaglutide, as demonstrated in the SELECT trial, has established long-term cardiovascular benefits, with an average weight loss of 10.2% over four years, highlighting its role in cardiometabolic risk reduction